Annet C.
- Country
- The Netherlands
- Department
- Internal medicine
Research Overview
Data & Insights
Has run more than one trial at 18 of 124 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in treating hormone receptor-positive (HR+) and HER2-negative breast cancer, with particular focus on advanced disease states including locally recurrent inoperable and metastatic conditions.
- Advanced Breast Cancer Treatment
- Hormone Receptor-Positive Disease
- Metastatic Breast Cancer
Special interest in treatment approaches for patients who have not received prior chemotherapy in the advanced setting.
Immunotherapy Applications
Focuses on investigating immunotherapeutic approaches in breast cancer treatment, particularly studying the role of PD-L1 expression and its impact on treatment outcomes.
- PD-L1 Targeted Therapy
- Combination Immunotherapy
- Biomarker Assessment
Expertise in evaluating immune response patterns in breast cancer patients.
Treatment Innovation
Investigates novel therapeutic combinations incorporating chemotherapy with targeted biological agents for breast cancer treatment. Specializes in response evaluation criteria and assessment methodologies.
- Combination Therapy Approaches
- Treatment Response Assessment
- Clinical Outcome Evaluation
Focuses on developing innovative treatment strategies for advanced breast cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.